<VariationArchive VariationID="2768644" VariationName="NM_022132.5(MCCC2):c.663del (p.Tyr222fs)" VariationType="Deletion" Accession="VCV002768644" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2926794" VariationID="2768644">
      <GeneList>
        <Gene Symbol="MCCC2" FullName="methylcrotonyl-CoA carboxylase subunit 2" GeneID="64087" HGNC_ID="HGNC:6937" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="71587340" stop="71658706" display_start="71587340" display_stop="71658706" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NT_187651.1" start="1117315" stop="1142082" display_start="1117315" display_stop="1142082" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NW_003315917.2" start="1585825" stop="1610592" display_start="1585825" display_stop="1610592" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NW_025791777.1" start="2074427" stop="2098393" display_start="2074427" display_stop="2098393" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="70883114" stop="70954530" display_start="70883114" display_stop="70954530" Strand="+" />
          </Location>
          <OMIM>609014</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_022132.5(MCCC2):c.663del (p.Tyr222fs)</Name>
      <CanonicalSPDI>NC_000005.10:71626676:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="71626677" stop="71626677" display_start="71626677" display_stop="71626677" variantLength="1" positionVCF="71626676" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="70922504" stop="70922504" display_start="70922504" display_stop="70922504" variantLength="1" positionVCF="70922503" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Y222fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.71626678del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.71626678del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.70922505del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.70922505del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008882.1" sequenceAccession="NG_008882" sequenceVersion="1" change="g.44391del">
            <Expression>NG_008882.1:g.44391del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022132.5" sequenceAccession="NM_022132" sequenceVersion="5" change="c.663del" MANESelect="true">
            <Expression>NM_022132.5:c.663del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_071415.1" sequenceAccession="NP_071415" sequenceVersion="1" change="p.Tyr222fs">
            <Expression>NP_071415.1:p.Tyr222fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363147.1" sequenceAccession="NM_001363147" sequenceVersion="1" change="c.625-5443del">
            <Expression>NM_001363147.1:c.625-5443del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022132.5(MCCC2):c.663del (p.Tyr222fs) AND 3-methylcrotonyl-CoA carboxylase 2 deficiency" Accession="RCV003499360" Version="1">
        <ClassifiedConditionList TraitSetID="488">
          <ClassifiedCondition DB="MedGen" ID="C1859499">3-methylcrotonyl-CoA carboxylase 2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11181649</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22642865</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="488" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">3-methylcrotonyl-CoA carboxylase 2 deficiency</ElementValue>
                <XRef ID="MONDO:0008862" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3 alpha methylcrotonyl-CoA carboxylase 2 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3 alpha methylcrotonylglycinuria 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCC 2 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylcrotonylglycinuria type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">METHYLCROTONYLGLYCINURIA, TYPE II</ElementValue>
                <XRef Type="MIM" ID="210210" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MCC2D</ElementValue>
                <XRef Type="MIM" ID="210210" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9151" />
                <XRef ID="9151" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-OH Acylcarnitine, Organic Acidemias, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH-Elevated.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Organic Acidemias: Elevated C5-OH, 2022</CitationText>
              </Citation>
              <XRef ID="6" DB="Orphanet" />
              <XRef ID="C1859499" DB="MedGen" />
              <XRef ID="MONDO:0008862" DB="MONDO" />
              <XRef Type="MIM" ID="210210" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8018856" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="28613062|MedGen:C1859499" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004329470" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11181649</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22642865</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr222Metfs*51) in the MCCC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MCCC2 are known to be pathogenic (PMID: 11181649, 22642865). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MCCC2-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MCCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.70922504del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1859499" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8018856" TraitType="Disease" MappingType="XRef" MappingValue="C1859499" MappingRef="MedGen">
        <MedGen CUI="C1859499" Name="3-methylcrotonyl-CoA carboxylase 2 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

